| Code | CSB-MP013227MO |
| Abbreviation | Recombinant Mouse Ltbr protein, partial (Active) |
| MSDS | |
| Size | $190 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Lymphotoxin-beta receptor orchestrates lymphoid organogenesis and immune homeostasis through its interactions with membrane-bound lymphotoxin heterotrimers and LIGHT, making precise characterization of these binding events essential for understanding secondary lymphoid tissue development and inflammatory signaling. This recombinant extracellular domain (aa 31–223) demonstrates quantifiable binding to human TNFSF14 with an EC50 of 15.43–18.78 ng/ml in functional ELISA, providing a validated reagent for ligand-binding assays, competitive inhibition studies, and blocking antibody screening campaigns targeting the LTβR–LIGHT axis. Mammalian expression preserves the native glycosylation and disulfide architecture critical for conformational integrity in receptor-ligand interaction studies, including surface plasmon resonance and biolayer interferometry experiments that demand physiologically relevant binding kinetics. The protein meets quality thresholds commonly required for therapeutic antibody epitope mapping and small-molecule inhibitor screening, with purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg to support cell-based functional assays.
There are currently no reviews for this product.